The latest edition of Australian
Prescriber includes an update on
medicines for smoking cessation.
As well as nicotine replacement
therapy, the respective roles of
varenicline (Champix from Pfizer),
bupropion (Zyban from Aspen,
or Prexaton from Ascent) and
e-cigarettes are discussed.
“While there is some evidence
that electronic cigarettes might
facilitate smoking cessation, quit
rates are not yet comparable with
those of the drugs approved on the
Pharmaceutical Benefits Scheme,”
said the authors.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Aug 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.